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Abstract
Background: The Vitamin D Receptor gene (VDR) is expressed in many tissues and modulates the expression of
several other genes. The purpose of this study was to investigate the association between metabolic syndrome
(MetSyn) with the presence of VDR 2228570 C > T and VDR 1544410 A > G polymorphisms in Brazilian adults.
Methods: Two hundred forty three (243) individuals were included in a cross-sectional study. MetSyn was classified
using the criteria proposed by National Cholesterol Educational Program - Adult Treatment Panel III. Insulin
resistance and β cell secretion were estimated by the mathematical models of HOMA IR and β, respectively. The
VDR 2228570 C > T and VDR 1544410 A > G polymorphisms were detected by enzymatic digestion and confirmed
by allele specific PCR or amplification of refractory mutation.
Results: Individuals with MetSyn and heterozygosis for VDR 2228570 C > T have higher concentrations of iPTH and
HOMA β than those without this polymorphism, and subjects with recessive homozygosis for the same
polymorphisms presented higher insulin resistance than those with the heterozygous genotype. There is no
association among VDR 1544410 A > G and components of MetSyn, HOMA IR and β, serum vitamin D (25(OH)D3)
and intact parathormone (iPTH) levels in patients with MetSyn. A significant lower concentration of 25(OH)D3 was
observed only in individuals without MetSyn in the VDR 1544410 A > G genotype. Additionally, individuals without
MetSyn and heterozygosis for VDR 2228570 C > T presented higher concentration of triglycerides and lower HDL
than those without this polymorphism.
Conclusions: Using two common VDR polymorphism data suggests they may influence insulin secretion, insulin
resistance an serum HDL-cholesterol in our highly heterogeneous population. Whether VDR polymorphism may
influence the severity of MetSyn component disorder, warrants examination in larger cohorts used for genome-
wide association studies.
Keywords: Vitamin D, Vitamin D Receptor gene, Polymorphisms, Parathyroid hormone, Metabolic syndrome
Background
The role of vitamin D for the development and mainte-
nance of bone tissue, as well as for maintaining normal
homeostasis of calcium and phosphorus is well established.
[1,2]. Currently, the involvement of vitamin D in the com-
ponents of metabolic syndrome has been suggested [3].
MetSyn is defined as a combination of medical disorders
that, when occurring together, increase the risk of develop-
ing cardiovascular disease and type 2 diabetes mellitus
(T2DM). Although the mechanisms underlying the role of
vitamin D in MetSyn remain incompletely explained, it
was showed that 25(OH)D3 could be related to the occur-
rence of reduced insulin secretion and sensitivity [4,5],
obesity [6,7], diabetes [8-10], and hypertension [11]. Add-
itionally, non-alcoholic fatty liver disease has been sug-
gested as an independent component of MetSyn [12] and a
low concentration of 25(OH)D3 might play a role in the
development and progression of such condition [13].
Activated vitamin D exerts its cellular functions by
modulating the transcription of target genes after bin-
ding to the nuclear Vitamin D Receptor (VDR) [14].
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Several polymorphisms have been reported for the VDR
gene such as ApaI (VDR 7975232 C > T), BsmI (VDR
1544410 A > G), FokI (VDR 2228570 C > T), and TaqI
(VDR 731236 T > C). Additionally, it has been demon-
strated that some of these polymorphisms are associated
with type 2 diabetes mellitus, insulin secretion [15,16],
as well as with metabolic changes related to obesity [14].
Besides the molecular evidence for the putative relation
between VDR polymorphism and such disorders remains
unclear, it has been demonstrated that a length of the
VDR, affected by the presence of the polymorphisms,
could lead a lower activation of target cells, since a lon-
ger VDR protein appears to have a decreased transcrip-
tional activity [17].
Although the relationship between vitamin D insuffi-
ciency and components of MetSyn has been previously
demonstrated [3,18], few studies have examined VDR
gene polymorphisms for associations with the risk of
these disorders [14,19,20]. Despite the high incidence of
year-round sunlight in Brazil, hypovitaminosis D has
been reported among different population groups in-
cluding teenagers, adult, and elderly [21-24]. On the
other hand, studies estimate that vitamin D concentra-
tions have a heritability of up to 53% [25], which could
be different in our population considering that we have
a genetically heterogeneous population.
Thus, this study was designed to investigate the associ-
ation of components of MetSyn with the presence of
polymorphisms in VDR gene [VDR 1544410 A > G
(BsmI); VDR 2228570 C > T (FokI)] in Brazilian adults
and has demonstrated associations between VDR gene
polymorphisms with insulin secretion, insulin resistance
and HDL-cholesterol, suggesting that these polymor-
phisms can affect metabolic syndrome phenotype.
Methods
Subjects, anthropometric measurements, and blood
pressure
This was a cross sectional study performed between
August 2007 and January 2009 in the city of São Paulo,
Brazil. Initially, 462 individuals from diabetes mellitus
prevention campaigns coordinated by the Primary
Healthcare Unit at the School of Public Health, Univer-
sity of São Paulo, and from the Adult Health Survey of
the City of São Paulo were invited to participate. Exclu-
sion criteria were: the presence of chronic illnesses that
potentially alter vitamin D metabolism, the use of medi-
cations that affect bone metabolism, afro-descendant
people, pregnant or breastfeeding women, and the use of
vitamin supplements. After the selection and removal of
individuals who did not accept participation, 243 blood
samples were collected for laboratory measurements and
genotyping. A signed consent form was obtained from
all participants and the ethics committee of the School
of Public Health from University of São Paulo approved
the study protocol.
Height was measured using a fixed stadiometer with a
vertical backboard and movable headboard, with subjects
standing on the floor. Weight was taken by asking each in-
dividual to stand at the center of the platform of a Tanita™
digital scale (Tanita Corporation of America Inc., Illinois,
USA). Body mass index [BMI =weight(kg)/height(m)2]
was calculated. Waist circumference was measured while
the subjects were standing up, with a tape placed at the
midpoint level between the lower intercostal border and
the anterior superior iliac supine while the subject was
gently exhaling. Blood pressure was obtained using an
automatic blood pressure monitor (Omron model HEM-
712C, Omron Health Care, Inc., USA). Three measures
were taken at rest in a sitting position, with intervals of
five minutes between the measurements. The average
from the measurements was taken for analysis. The sub-
jects were also asked about their use of sunscreen and
practice of outdoor physical activities. Participants were
further divided into two groups, with and without MetSyn,
according to criteria adopted by NCEP – ATP III. Briefly,
waist circumference ≥ 102 cm for men, ≥ 88 cm for
women; fasting glucose ≥ 110 mg/dl; triglycerides ≥
150 mg/dl; HDL-cholesterol < 40 g/dl for men, <50 mg/dl
for women; blood pressure systolic ≥ 130 mm Hg or dia-
stolic ≥ 85 mmHg [26].
Biochemical analyses of blood samples
Blood samples were obtained by venipuncture after an
overnight fast and immediately centrifuged, aliquoted and
frozen at -80°C until the beginning of analyses. Serum
levels of 25(OH)D3 were measured by High Performance
Liquid Chromatography (HPLC; Immundiagnostik AG,
Germany). Serum levels of intact parathyroid hormone
(iPTH) were measured by a electrochemiluminescence
assay (Roche Diagnostics™, Brazil), in which, intra and
interassay CVs were both 6% with a normal range of 10-
65 pg/ml. Serum total levels of calcium were measured by
colorimetrical assay (Bioclin™, Brazil), normal range 8.6-
10.2 mg/dl. Fasting glucose, total cholesterol and fractions,
and triglycerides were determined by enzymatic colori-
metric assay (Celm™, Brazil). For these variables, the cut-
offs for diagnosis of MetSyn used were those of the
NCEP-ATP III [26]. Moreover, plasma insulin was assayed
by chemiluminescence (IMMUNOLITE® commercial kit,
Siemens Health Diagnostics, USA), and insulin resistance
was estimated by the homeostatis model assessment of
insulin resistance (HOMA-IR), by the following equation:
HOMA−IR ¼ fasting glucose X fasting insulinð Þ=22:5
where fasting glucose and fasting insulin are described
in nmol/l and mU/ml, respectively [26]. In addition,
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HOMA-β-cell function was also calculated by the fol-
lowing formula:
HOMA−β ¼ 20 X fasting insulinð Þ= fasting glucose–3:5ð Þ
where fasting insulin and fasting glucose are described
in μU/ml and mmol/L, respectively [27].
Genotyping
Genomic DNA was extracted from the whole blood
using the salting out method [28]. After extraction, the
quality of the extracted material was visualized in 1%
agarose gel and the concentration was obtained by a
spectrophotometer Nanodrop 8000 (Thermo Scientific,
USA). Genotyping of BsmI (VDR 1544410 A > G) and
FokI (VDR 2228570 C > T) polymorphisms in the VDR
gene was performed using a technique known as allele
specific polymerase chain reaction (ASPCR) or amplifi-
cation refractory mutation (ARMs) [29]. Detection of
the products was made using fluorescence resonance en-
ergy. PCRs were carried out with ArrayTape instrumen-
tation, and allele calls were generated based on the
clustering of fluorescent signals. Only genotypes with a
level of confidence ≥90% were included in the analysis.
Statistical analysis
Descriptive data were expressed as mean and standard
deviation. Normality of the distribution of each variable
was analyzed by Kolmogorov-Smirnov test. Logarithmic
transformation was performed to obtain a normal distri-
bution for skewed variables (iPTH, BMI, waist circumfe-
rence, HOMA IR, HOMA β, triglycerides, and HDL-
cholesterol). One-way analysis of variance (ANOVA) was
used to examine the variation in different MetSyn vari-
ables with the genotypes and for adjustment according to
age. Differences between the genotypes were assessed by
using the Bonferroni LSD test (post-hoc test). Allelic fre-
quencies were estimated by gene counting and genotypic
distribution of polymorphisms, and tested for Hardy-
Weinberg equilibrium (HWE), by Chi-square analysis.
HWE assumes a stable population of adequate size with-
out selective pressures and is used in human genetic stu-
dies as a guide to data quality by comparing observed
genotype frequencies to those expected within a popula-
tion. Logistic regression analysis was performed to evalu-
ate associations between clinical and genetic variables.
Gender, age, elevated waist circumference, increased
glucose fasting levels, presence of arterial hypertension,
increased triglycerides levels, decreased HDL cholesterol,
increased total cholesterol levels, presence of MetSyn,
HOMA IR and β, increased iPTH, and 25(OH)D3 levels
were included as independent variables, and the pres-
ence or absence of VDR gene polymorphisms was cha-
racterized as categorical dependent variables. Analyses
were conducted with Package for the Social Science SPSS
software for Windows, version 18 (SPSS Inc., USA). Sta-
tistical significance was assumed when p values were
< 0.05.
Results
General characteristics of study population
The participants mean age was 51 (±15) years and BMI 26
(± 6) kg/m2. Thirty nine percent was male and 61% fe-
male. MetSyn was present in 48% of the population. As
expected, BMI, waist circumference, blood pressure,
fasting glucose, total cholesterol and LDL-cholesterol were
significantly higher in individuals with MetSyn, except for
HDL cholesterol (44 ±12 vs 41 ±11 mg/dl, p < 0.000).
Mean study population vitamin D status was insufficient
(22.8 ng/ml), the mean of 25(OH)D3 was significantly
lower among people without MetSyn (22.8 ± 7.2 vs 24.4 ±
7.6 ng/ml, p = 0.003 respectively). No significant diffe-
rences were observed for iPTH and serum levels of cal-
cium between the groups with and without MetSyn.
Distribution of VDR 1544410 A > G (BsmI) and VDR
2228570 C > T (FokI) gene polymorphisms
Following the genotyping the distribution of both VDR
BsmI and VDR FokI polymorphisms was performed in
those with or without MetSyn. Table 1 shows the fre-
quency of these polymorphisms. Besides the lower fre-
quency of normal dominant homozygous genotype FF and
also BB among individuals without MetSyn, there is no
difference in genotype frequencies for either polymor-
phisms, thus demonstrating Hardy-Weinberg equilibrium.
VDR 1544410 A > G (BsmI) and VDR 2228570 C > T (FokI)
gene polymorphisms and the findings for variables used
to demonstrate the presence or absence of metabolic
syndrome
The associations among VDR gene polymorphisms, vita-
min D status, and the components of MetSyn were
Table 1 Genotype distribution of VDR gene
polymorphisms among individuals with and without
MetSyn
Genotype With MetSyn Without MetSyn p-value
Distribution (%) n = 116 n = 127
FokI FF 13 8
(VDR 2228570 C > T) Ff 47 57
ff 40 35 p = 0.16
BsmI BB 20 9
(VDR 1544410 A > G) Bb 43 41
bb 37 50 p = 0.79
Legend: the distribution of the VDR polymorphisms is in Hardy-Weinberg
equilibrium. Normal dominant homozygous genotype “FF, BB”; heterozygous
genotype “Ff, Bb”; mutant recessive homozygous genotype “ff, bb”.
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evaluated separately according to the presence or ab-
sence of MetSyn.
Table 2 presents the distribution of all clinical vari-
ables according to the genotypes observed in individuals
with MetSyn. No association between VDR BsmI poly-
morphism was observed with the components of
MetSyn, 25(OH)D3, or iPTH. However, individuals car-
rying the mutant recessive homozygous ff genotype
presented a significantly higher insulin resistance index
(HOMA-IR) than individuals with the heterozygous Ff
genotype. Additionally, the presence of at least one f for
the VDR FokI polymorphism was associated with higher
β-cell secretion (HOMA-β) and iPTH concentrations,
them were seen in those with the F allele.
Then, the same analyses were performed for the group
of individuals without MetSyn. These results are present
in Table 3. In addition, higher serum triglycerides and
lower HDL concentrations were seen in subjects with
both the F and f FokI polymorphism. Whilst bb homozy-
gous for the BsmI VDR variant was associated with
lower 25(OH)D3 values than seen in others. Additionally,
the values of diastolic and systolic blood pressure, fasting
glucose and waist circumference were very similar
among all participants, independently of presence or ab-
sence of both VDR BsmI and FokI polymorphisms.
Finally, data for all subjects was used for multiple logistic
regression to determine associations of VDR polymorphism
with MetSyn and its components - Table 4. HDL-cholesterol
showed variation with FokI polymorphism (odds ratio,
0.967, β= -0.032; 95% CI = 0.945-0.993; p = 0.01), but no
other MetSyn component varied withVDR genotype.
Discussion
Our findings suggest that VDR gene polymorphisms may
influence the severity of MetSyn component disorder. In
individuals with MetSyn, the VDR 2228570 C > T (FokI)
polymorphism appeared to be associated with insulin sen-
sitivity and iPTH concentration. Additionally, in individ-
uals without MetSyn, this polymorphism was associated
with higher triglycerides and lower HDL levels. Further-
more, when considering all individuals, HDL cholesterol
varied independently with VDR FokI polymorphism. In
support of the findings, Oh and Barrett-Connor (2002) in-
vestigating VDR gene polymorphisms in individuals with
type 2 diabetes in the Rancho Bernando Cohort, observed
that individuals with the mutant recessive homozygous
genotype, the VDR 1544410 A >G (BsmI) polymorphism,
presented significantly higher levels of HOMA-IR com-
pared to those with heterozygous or normal homozygous
genotypes [20].
Since the early 1980’s, it has been demonstrated that
pancreatic insulin secretion is inhibited by vitamin D de-
ficiency, suggesting a role for this vitamin in the regula-
tion of endocrine pancreatic function, especially in the
β cell [30]. In addition, the non-genomic pathway
dependent on membrane VDR protein promotes rapid
calcium fluxes important in inducing effects of vitamin
D on insulin release [31-34]. It is already known that
1,25(OH)2D3 directly influences β cell insulin secretion
through the induction of increases in intracellular free
calcium concentration through voltage-dependent Ca2+
channels [35]. Moreover, though glycemia is a major
major characteristic of diabetes mellitus type 2, no asso-
ciation was found between fasting glycemia and VDR
gene polymorphisms evaluated in this cohort. Similarly,
Malecki and coworkers (2003) have investigated BsmI,
TaqI, and FokI VDR gene polymorphisms in 548 Polish
individuals with and without T2DM and did not found
any association of glycemia with any of the VDR gene
polymorphisms either [36].
Table 2 Mean values of all variables by VDR genotype in subjects with MetSyn
Variables VDR 2228570 C > T (Fok I) p VDR 1544410 A > G (Bsm I) p
FF Ff ff BB Bb bb
n = 130 n = 91 n = 22 n = 109 n = 102 n = 32
WC (cm) 103 (±13) 103 (±12) 106 (±13) 0.433 104 (±13) 103 (±13) 104 (±13) 0.863
Triglycerides (mg/dl) 155 (±59) 174 (±81) 163 (±103) 0.204 151 (±59) 173 (±87) 163 (±64) 0.523
BPS (mmHg) 140 (±18) 137 (±16) 147 (±24) 0.377 139 (±14) 139 (±20) 134 (±20) 0.490
BPD (mmHg) 84 (±12) 82 (±10) 85 (±12) 0.726 84 (±10) 83 (±10) 82 (±8) 0.822
Fasting glucose (mg/dl) 99 (±10) 98 (±13) 99 (±14) 0.707 100 (±12) 97 (±13) 99 (±12) 0.404
HDL cholesterol (mg/dl) 43 (±12) 40 (±9) 40 (±12) 0.306 43 (±12) 42 (±10) 40 (±12) 0.231
HOMA IR 2 (±2) 3 (±2) 4 (±3)† 0.014 3 (±1) 3 (±2) 4 (±3) 0.259
HOMA β 100 (±77) 159 (±137)‡ 145 (±61) 0.010 123 (±77) 142 (±137) 137 (±107) 0.729
25(OH)D3 (ng/ml) 24 (±6.8) 24.8 (±16.8) 24 (±8) 0.828 24 (±6.4) 62 (±8.4) 24 (±8) 0.389
iPTH (pg/dl) 37 (±19) 49 (±22)‡ 42 (±25) 0.022 44 (±15) 49 (±22) 46 (±25) 0.649
Legend: WC, Waist circumference; BPS, Systolic blood pressure; BPD, Diastolic blood pressure; HOMA IR, Insulin resistance; HOMA β, Cell function; iPTH, Intact
parathyroid hormone; 25(OH)D3, Vitamin D. Data are expressed as mean (Standard Deviation). P values were calculated using ANOVA followed by Bonferroni test
and adjusted for age. † significant for the heterozygous genotype; ‡ significant for the normal dominant homozygous genotype.
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On the other hand, the association of MetSyn with in-
creased cardiovascular disease may be modulated by
non-bony effects of vitamin D such as those on lipid
profiles. This possibility is supported by an investiga-
tion on whether lack of vitamin D has effect on choles-
terol metabolism where serum concentrations of HDL
cholesterol was found to be 22% higher in VDR knock-
out compared to wild type mice [37]. In contrast, differ-
ent results were observed in humans in the NHANES
2000–2004 survey, which demonstrated that vitamin D
deficiency (< 15 ng/mL) was associated with lower
concentrations of HDL cholesterol in adults [38]. Re-
sults of this study corroborate the latter study, in
suggesting that VDR gene polymorphism associated
with lower serum 25(OH)D3 [24], may be linked to
lower HDL-cholesterol in adults.
There are three mechanisms by which our data suggests
that the vitamin D-VDR axis could affect lipid profiles.
First: Vitamin D induced suppression of PTH secretion,
and it has been reported that PTH could reduce lipolysis
[39]. Second: Vitamin D increases intestinal calcium ab-
sorption and this can trigger a decrease in serum triglycer-
ides levels by reducing the hepatic triglyceride formation
and secretion [40], and Third: Vitamin D might improve
insulin secretion and insulin sensitivity, thereby indirectly
influencing lipid metabolism [41].
In the present study, important associations were also
identified for both VDR 2228570 C > T (FokI) or VDR
1544410 A >G (BsmI) polymorphism in individuals with-
out MetSyn. The higher triglycerides and lower HDL in
heterozygous VDR 2228570 C > T (FokI) as well lower 25
(OH)D3 in homozygous recessive VDR 1544410 A >G
(BsmI), could be related to the overweight/obese condition
of the individuals. There are likely to be many genetic fac-
tors in addition to the VDR 1544410 A >G and VDR
2228570 C > T gene polymorphisms that are involved in
determination of MetSyn risk. Despite this our data sug-
gests that VDR polymorphisms may contribute to MetSyn
component severity such as insulin secretion, insulin re-
sistance and HDL-cholesterol, findings that warrant fur-
ther examination in larger cohorts with data permitting
genome wide association studies to be made.
Conclusions
It is known that vitamin D insufficiency is present in
about one billion people worldwide and that this high
Table 3 Mean values of all variables by VDR genotype in subjects without MetSyn
Variables VDR 2228570 C > T (Fok I) p VDR 1544410 A > G (Bsm I) p
FF Ff ff BB Bb bb
n = 130 n = 91 n = 22 n = 109 n = 102 n = 32
WC (cm) 89 (±10) 95 (±16) 90 (±9) 0.086 93 (±14) 93 (±13) 86 (±11) 0.293
Triglycerides (mg/dl) 90 (±28) 117 (±54)‡ 134 (±80) 0.005 107 (±46) 113 (±58) 100 (±45) 0.696
BPS (mmHg) 122 (±17) 121 (±21) 124 (±14) 0.923 119 (±21) 125 (±16) 121 (±21) 0.194
BPD (mmHg) 75 (±10) 76 (±14) 79 (±10) 0.316 75 (±13) 77 (±11) 74 (±14) 0.556
Fasting glucose (mg/dl) 92 (±10) 92 (±11) 89 (±10) 0.607 92 (±11) 90 (±9) 93 (±8) 0.588
HDL cholesterol (mg/dl) 50 (±11) 45 (±12)‡ 42 (±11) 0.031 47 (±13) 47 (±11) 42 (±6) 0.253
Homa IR 1.6 (±1.4) 1.7 (±1.4) 1.0 (±0.4) 0.398 1.7 (±1.7) 1.6 (±0.9) 1.2 (±0.7) 0.749
Homa β 92 (±62) 103 (±80) 87 (±93) 0.711 96 (±81) 107 (±71) 70 (±46) 0.424
25(OH)D3 (ng/ml) 20 (±6) 22 (±6.4) 24.4 (±5) 0.062 20.8 (±6) 23 (±6.4) 18 (±7.2)† 0.023
iPTH (pg/dl) 41 (±24) 36 (±18) 38 (±11) 0.019 40 (±20) 37 (±20) 32 (±24) 0.361
Legend: WC, Waist circumference; BPS, Systolic blood pressure; BPD, Diastolic blood pressure; HOMA IR, Insulin resistance; HOMA β, Cell function; iPTH, Intact
parathyroid hormone; 25(OH)D3, Vitamin D. Data are expressed as mean (Standard Deviation). P values were calculated using ANOVA followed by Bonferroni test
and adjusted for age. † significant for the heterozygous genotype; ‡ significant for the normal dominant homozygous genotype.
Table 4 Logistic regression of traits associated with the
presence of VDR 2228570 C > T (Fok I) polymorphism in
the study population
Variables B Odds ratio p 95% confidence interval
Lower Upper
Age 0.014 1.014 0.244 0.991 1.037
Gender -0.395 0.674 0.357 0.291 1.561
WC 0.007 1.007 0.662 0.977 1.037
Blood pressure 0.009 1.009 0.594 0.977 1.042
Glucose fasting 0.041 1.041 0.136 0.987 1.099
Triglycerides 0.005 1.005 0.187 0.998 1.012
HDL cholesterol -0.032 .967 0.011 0.945 0.993
Total cholesterol 0.005 1.005 0.310 0.996 1.014
MetSyn -0.136 0.474 0.239 0.696 1.095
HOMA IR -0.128 0.880 0.558 0.573 1.351
HOMA β 0.007 1.007 0.112 0.998 1.017
iPTH 0.000 1.000 0.970 0.985 1.016
25(OH)D3 0.007 1.007 0.536 0.985 1.029
Legend: WC, Waist circumference; MetSyn, Metabolic syndrome; HOMA IR
Insulin resistance; HOMA β, cell function; iPTH, Intact parathyroid hormone; 25
(OH)D3, Vitamin D.
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prevalence is independent of location, age and socioeco-
nomic or cultural levels, and is mainly related to inadequate
sun exposure aggravated by inadequate consumption of
foods containing this vitamin. Although the relationship be-
tween vitamin D status and bone outcomes is well
established [42], other studies have shown increasing evi-
dence of strong associations between vitamin D and
chronic diseases, among which is the metabolic syndrome
and its component abnormalities as well T2DM and car-
diovascular disease [43].
Evidence from the present study suggests an inter-
action between VDR gene polymorphisms and important
components of MetSyn, an area where little previous
work has been done. Using two common VDR polymor-
phisms data from this study suggest that 2 major VDR
gene polymorphisms (VDR 1544410 A > G and VDR
2228570 C > T) may be linked to insulin secretion and
resistance and to the degrees of reduction in serum
HDL cholesterol. This evidence is in line with previous
reports and suggests the need to examine data from lar-
ger cohorts, such as those where vitamin D axis genes
were examined in GWAS [24], and to examine the ef-
fects of adequate vitamin D supplementation on all com-
ponents of the metabolic syndrome and to determine
any such effects are modulated by vitamin D axis related
gene polymorphisms.
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